New AI Model Links Insulin Resistance to Higher Cancer Risk

A new AI tool is changing how doctors assess insulin resistance and its link to cancer. Researchers at the University of Tokyo Hospital have developed AI-IR, an AI model that uses routine health data to identify high-risk individuals. The findings suggest insulin resistance may play a bigger role in cancer risk than previously thought.

The study, led by Yuta Hiraike, introduces AI-IR as a more reliable way to measure insulin resistance than traditional methods like BMI. Unlike direct testing—which requires specialised clinics—the AI model analyses nine standard health check-up parameters. This makes it far easier to use on a large scale.

Tests showed AI-IR was more accurate at spotting insulin resistance than BMI. The tool also provided the first population-level evidence linking insulin resistance to higher cancer risk. While earlier research lacked clear data, this study confirms the connection.

Researchers are now examining how genetic differences affect individual cancer risks. The goal is to refine AI-IR further, helping doctors target screening and prevention efforts more effectively.

The AI-IR model could soon become a standard part of health assessments. By improving early detection of insulin resistance, it may help reduce cancer cases alongside diabetes and heart disease. Hospitals and clinics may adopt the tool to better identify at-risk patients in routine check-ups.